Steven R. Sarkisian, Jr., MD


Clinical Professor
Glaucoma Fellowship Director


Clinical focus

Special interests
Nanotechnology applications for the treatment of glaucoma; Innovation in glaucoma surgery; and Glaucoma Drainage Devices

  • MD, Jefferson Medical College, Philadelphia, Pennsylvania
  • Residency: Department of Ophthalmology, State University of New York Health Science Center, (SUNY Downstate Medical Center), Brooklyn, New York
  • Fellowship: Department of Ophthalmology, University of Tennessee Health Science Center, Memphis, Tennessee

Steven R. Sarkisian, Jr., MD | Dean McGee Eye Institute 

Steven R. Sarkisian, Jr., MD is the director of the glaucoma fellowship at the Dean McGee Eye Institute and serves as a clinical professor of Ophthalmology at the University of Oklahoma in Oklahoma City. A native of Pennsylvania, Dr. Sarkisian received his undergraduate degree from Wheaton College, in Illinois where he graduated with honors. Following college, Dr. Sarkisian did graduate work at Westminster Theological Seminary in Philadelphia. Remaining in Philadelphia, he received his M.D. degree from Jefferson Medical College followed by an internship at Chestnut Hill Hospital. Dr. Sarkisian completed an ophthalmology residency at the State University of New York Health Science Center (SUNY Downstate) in Brooklyn, New York and did a fellowship in glaucoma at the Hamilton Eye Institute at the University of Tennessee Health Science Center in Memphis, following which he was asked to stay on the faculty where he served until July 2006. Dr. Sarkisian joined the faculty at the Dean A. McGee Eye Institute in August 2006.

Dr Sarkisian has an active interest in surgical innovation for the treatment of glaucoma with involvement in numerous clinical trials. He is the Primary Investigator for the Ologen vs. Mitomycin-C study, a multicenter, prospective randomized trial comparing these two methods of wound modulation in glaucoma filtration surgery as well as numerous other studies currently underway investigating devices in multiple stages of the FDA approval process for the surgical treatment of glaucoma. He has served as Primary Investigator on the Ex-Press vs. trabeculectomy trial (XVT Study), the Ahmed-Baerveldt Comparison Trial (ABC Study) and for the pilot studies which have taken place for the EagleVision glaucoma drainage implants. He has been a co-investigator on the Trabeculectomy vs. Tube Study (TVT Study), the Primary Trabeculectomy vs. Tube Study (PTVT), and the Anecortave Acetate study. Due to his involvement in the development of new glaucoma technology, he has been active in presenting and publishing his work both in America and internationally. He also was nominated by the American Glaucoma Society to be a consultant to the FDA Ophthalmic Device Panel, where he has served since 2009.

Dr. Sarkisian currently serves on the Editorial Board of Glaucoma Today and is an editorial reviewer for numerous ophthalmology journals. His professional service also includes membership on the glaucoma program committee for both the American Society of Cataract and Refractive Surgery (ASCRS) and the American Academy of Ophthalmology (AAO). He has served as a moderator and speaker at the annual meetings of the ASCRS and the AAO as well as the ASCRS Winter Update Meeting. His responsibilities also include reviewing all wet labs/skills courses, as well as abstracts for poster/paper presentations related to glaucoma for both the ASCRS and AAO. He also is the Program Chairman for the University of Oklahoma Department of Ophthalmology Annual Ophthalmology Symposium.

Dr. Sarkisian is listed in Woodward/White’s The Best Doctors in America, and among America’s Top Ophthalmologists by the Consumers’ Research Council of America. He is also listed in Cambridge Who’s Who and the Global directory of Who’s Who and has been listed among The Best Doctors in Oklahoma by Oklahoma Magazine.

Dr. Sarkisian has retained an interest in biomedical ethics, having served on the Professional Code of Conduct Committee at Jefferson Medical College, the Ethics Committee of Chestnut Hill Hospital, and the UT Faculty Senate. He also has been active in organized medicine, having served as President of the Jefferson Chapter of the AMA. He also served as a Trustee of the Pennsylvania Medical Society as a medical student.

Certified by the American Board of Ophthalmology, Dr. Sarkisian is also a member of the American Glaucoma Society, the Chandler-Grant Glaucoma Society, the American Academy of Ophthalmology, the American Medical Association, the Association for Research in Vision and Ophthalmology, the American Society of Cataract and Refractive Surgery, and numerous local and state ophthalmology societies.

He and his wife Anne have four children and reside in Edmond, Oklahoma.

Website by myheartcreative. Managed by Webvis CMS